MedPAC’s Message To Congress: Drug Pricing Still Needs Attention

 
• By Michael McCaughan
  
MEDPAC's reform efforts will continue to inject uncertainty into Part B • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access